» Articles » PMID: 11886845

UDP-GlcNAc Concentration is an Important Factor in the Biosynthesis of Beta1,6-branched Oligosaccharides: Regulation Based on the Kinetic Properties of N-acetylglucosaminyltransferase V

Overview
Journal Glycobiology
Date 2002 Mar 12
PMID 11886845
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Human beta1,6-N-acetylglucosaminyltransferase V (GnT-V) was expressed by baculovirus-insect cell system, and the purified recombinant enzyme was kinetically characterized. The data obtained were used to establish the kinetic basis of the substrate specificity toward donor nucleotide sugars, and also revealed that K(m) values for the donors are much higher compared to those of other GlcNAc transferases, the kinetic properties of which have been reported. Because this exceptionally higher K(m) suggests that GnT-V is physiologically present at far from saturated conditions, it would appear that the production of beta1,6-branched oligosaccharide, which is formed by GnT-V, could be regulated in vivo by the concentration of the donor, UDP-GlcNAc, as well as the expression levels of the enzyme. When B16 melanoma cells, which express high levels of GnT-V, were incubated with GlcNAc, the beta1,6-branched oligosaccharide levels were increased, as judged by a lectin blot analysis, in conjunction with an increase in intracellular UDP-GlcNAc. These findings suggest that the level of UDP-GlcNAc can be a critical factor in the production of beta1,6-branched oligosaccharides, for example, by tumor cells, which have been thought to be closely associated with tumor progression and metastasis.

Citing Articles

Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression.

de-Souza-Ferreira M, Ferreira E, de-Freitas-Junior J Cell Oncol (Dordr). 2023; 46(3):481-501.

PMID: 36689079 DOI: 10.1007/s13402-023-00770-4.


Increased levels of acidic free-N-glycans, including multi-antennary and fucosylated structures, in the urine of cancer patients.

Hanzawa K, Tanaka-Okamoto M, Murakami H, Suzuki N, Mukai M, Takahashi H PLoS One. 2022; 17(4):e0266927.

PMID: 35413075 PMC: 9004742. DOI: 10.1371/journal.pone.0266927.


Structure-based design of UDP-GlcNAc analogs as candidate GnT-V inhibitors.

Vibhute A, Tanaka H, Mishra S, Osuka R, Nagae M, Yonekawa C Biochim Biophys Acta Gen Subj. 2022; 1866(6):130118.

PMID: 35248671 PMC: 9947920. DOI: 10.1016/j.bbagen.2022.130118.


Siglec Signaling in the Tumor Microenvironment.

van Houtum E, Bull C, Cornelissen L, Adema G Front Immunol. 2021; 12:790317.

PMID: 34966391 PMC: 8710542. DOI: 10.3389/fimmu.2021.790317.


Crosstalk of the IκB Kinase with Spliced X-Box Binding Protein 1 Couples Inflammation with Glucose Metabolic Reprogramming in Epithelial-Mesenchymal Transition.

Zhao Y, Zhang J, Sun H, Brasier A J Proteome Res. 2021; 20(7):3475-3488.

PMID: 34124911 PMC: 9517173. DOI: 10.1021/acs.jproteome.1c00093.